Compare AMPH & FPF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AMPH | FPF |
|---|---|---|
| Founded | 1996 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.1B |
| IPO Year | 2005 | N/A |
| Metric | AMPH | FPF |
|---|---|---|
| Price | $19.51 | $17.83 |
| Analyst Decision | Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $30.29 | N/A |
| AVG Volume (30 Days) | ★ 594.4K | 124.3K |
| Earning Date | 05-06-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.08% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.03 | N/A |
| Revenue | ★ $719,887,000.00 | N/A |
| Revenue This Year | $7.19 | N/A |
| Revenue Next Year | $4.76 | N/A |
| P/E Ratio | $9.64 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $17.03 | $15.60 |
| 52 Week High | $31.26 | $19.75 |
| Indicator | AMPH | FPF |
|---|---|---|
| Relative Strength Index (RSI) | 37.33 | 34.59 |
| Support Level | $17.03 | N/A |
| Resistance Level | $29.30 | $18.88 |
| Average True Range (ATR) | 0.77 | 0.26 |
| MACD | 0.29 | -0.04 |
| Stochastic Oscillator | 81.31 | 28.73 |
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.
First Trust Inter Dur Pref& Income Fund is a diversified, closed-end management investment company. Its primary investment objective is to seek a high level of current income. Further, it has a secondary objective of capital appreciation. The Fund invests in the traditional preferred securities, hybrid preferred securities, floating rate & fixed-to-floating rate preferred securities, debt securities, convertible securities, and contingent convertible securities issued by U.S. and non-U.S. companies. Its investment portfolio includes industries such as Banks, Insurance, Capital Markets, Electric Utilities, Oil, Gas & Consumable Fuels, Food Products, and others.